Franklin Resources Inc Dyne Therapeutics, Inc. Transaction History

Franklin Resources Inc

  • $356 Billion
  • Q2 2025

A detailed history of Franklin Resources Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,390,140 shares of DYN stock, worth $22.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,390,140
Previous 1,414,835 1.75%
Holding current value
$22.3 Million
Previous $14.8 Million 10.58%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$6.81 - $14.78 $168,172 - $364,992
-24,695 Reduced 1.75%
1,390,140 $13.2 Million
Q1 2025

May 13, 2025
BUY
$10.46 - $25.46 $952,194 - $2.32 Million
91,032 Added 6.88%
1,414,835 $14.8 Million
Q4 2024

Feb 12, 2025
SELL
$23.56 - $35.55 $440,501 - $664,678
-18,697 Reduced 1.39%
1,323,803 $31.2 Million
Q3 2024

Nov 12, 2024
SELL
$31.94 - $47.04 $11.9 Million - $17.5 Million
-371,996 Reduced 21.7%
1,342,500 $48.2 Million
Q2 2024

Aug 14, 2024
SELL
$23.65 - $35.63 $1.63 Million - $2.45 Million
-68,775 Reduced 3.86%
1,714,496 $60.5 Million
Q1 2024

May 13, 2024
SELL
$13.06 - $29.18 $1.71 Million - $3.81 Million
-130,561 Reduced 6.82%
1,783,271 $50.6 Million
Q4 2023

Feb 09, 2024
BUY
$6.62 - $13.64 $5,799 - $11,948
876 Added 0.05%
1,913,832 $25.5 Million
Q3 2023

Nov 13, 2023
SELL
$8.6 - $12.18 $4,497 - $6,370
-523 Reduced 0.03%
1,912,956 $17.1 Million
Q2 2023

Aug 11, 2023
BUY
$8.53 - $14.28 $180,153 - $301,593
21,120 Added 1.12%
1,913,479 $21.5 Million
Q1 2023

May 12, 2023
BUY
$10.88 - $15.0 $1.24 Million - $1.71 Million
114,058 Added 6.41%
1,892,359 $21.8 Million
Q4 2022

Feb 10, 2023
SELL
$9.37 - $13.8 $42,820 - $63,066
-4,570 Reduced 0.26%
1,778,301 $20.6 Million
Q3 2022

Nov 14, 2022
BUY
$7.2 - $15.17 $262,008 - $552,036
36,390 Added 2.08%
1,782,871 $22.6 Million
Q2 2022

Aug 11, 2022
BUY
$4.36 - $10.5 $2.48 Million - $5.97 Million
568,533 Added 48.26%
1,746,481 $12 Million
Q1 2022

May 13, 2022
SELL
$6.52 - $12.27 $94,214 - $177,301
-14,450 Reduced 1.21%
1,177,948 $11.4 Million
Q4 2021

Feb 11, 2022
BUY
$11.89 - $16.07 $841,633 - $1.14 Million
70,785 Added 6.31%
1,192,398 $14.2 Million
Q3 2021

Nov 12, 2021
BUY
$15.6 - $21.46 $1.34 Million - $1.84 Million
85,666 Added 8.27%
1,121,613 $18.2 Million
Q2 2021

Aug 13, 2021
BUY
$15.94 - $22.33 $1.67 Million - $2.34 Million
104,742 Added 11.25%
1,035,947 $21.8 Million
Q1 2021

May 13, 2021
SELL
$14.0 - $29.3 $7.99 Million - $16.7 Million
-571,000 Reduced 38.01%
931,205 $14.5 Million
Q4 2020

Feb 10, 2021
SELL
$16.81 - $23.94 $4.12 Million - $5.87 Million
-245,352 Reduced 14.04%
1,502,205 $31.5 Million
Q3 2020

Nov 12, 2020
BUY
$20.0 - $23.9 $35 Million - $41.8 Million
1,747,557 New
1,747,557 $35.3 Million

Others Institutions Holding DYN

# of Institutions
212
Shares Held
122M
Call Options Held
36.5K
Put Options Held
74.3K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $830M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email